Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 235–235 | Cite as

Lu 177 octreotide/lutetium (177Lu) oxodotreotide/lutetium 177 PSMA imaging and therapy

Tumour lysis syndrome: 4 case reports
Case report
  • 6 Downloads

Reference

  1. Huang K, et al. Tumor lysis syndrome: A rare but serious complication of radioligand therapies. Journal of Nuclear Medicine 60: 752-755, No. 6, Jun 2019. Available from: URL: http://doi.org/10.2967/jnumed.118.217380 - GermanyCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations